Phase 3 KEEPsAKE 1 trial reveals promising efficacy and safety profile of risankizumab in treating active psoriatic arthritis”
Study shows comparable effectiveness of tofacitinib and adalimumab in treating axial spondylarthritis
Swedish cohort study validates the safety of hydroxychloroquine in rheumatic disease during pregnancy
Study reveals significant association between depression and rheumatoid arthritis in individuals with obesity and hypertriglyceridemia
New study shows 14-3-3η proteins as diagnostic marker, disease indicator, and lymphoma predictor for primary Sjögren’s syndrome
